The availability of priority medicines for children under 5 years in eThekwini, South Africa
Background Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study investigated accessibility, availability and affordability of a basket of priorit...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1186/s40545-021-00402-y |
| _version_ | 1797401292595789824 |
|---|---|
| author | Shannice Mahadeo Keshmika Narain Lungelo Mhlongo Desmaine Chetty Lindelani Masondo Mandla Zungu Fatima Suleman Velisha Ann Perumal-Pillay |
| author_facet | Shannice Mahadeo Keshmika Narain Lungelo Mhlongo Desmaine Chetty Lindelani Masondo Mandla Zungu Fatima Suleman Velisha Ann Perumal-Pillay |
| author_sort | Shannice Mahadeo |
| collection | DOAJ |
| description | Background Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study investigated accessibility, availability and affordability of a basket of priority medicines for children under 5 years in public and private healthcare sector pharmacies in the eThekwini Metropolitan area in Durban, South Africa. Methods The WHO/HAI survey tool for assessing medicine prices, availability and affordability was adapted and employed for a basket of WHO Priority life-saving medicines for children under 5 years. Six district hospitals in the north, south and central eThekwini Metropolitan were selected as major facility reference points and for data collection and pharmacies within a 5 km radius from each major facility were also invited to participate in the study, as outlined in the WHO/HAI tool methodology. Of the 58 pharmacies selected, a total of 27 pharmacies from both private and public healthcare sectors agreed to participate and were surveyed, representing a 47% response rate. Data was analysed using Microsoft excel. Results All participating pharmacies (and hence the selected basket of priority medicines at these facilities) were deemed accessible. Overall the public sector had more medicines available on the shelf (averaging 64%) than the private sector (48%) which had more medicines available on order (84%). At least one medicine for each of the eight (8) conditions was available at both sectors which meant patients could be treated for these conditions. Medicines for priority conditions (except HIV, which was a 28-day course) were deemed affordable as these regimens were obtainable within a day’s wage for the lowest paid unskilled worker. Priority medicines for children under 5 years were more available and more affordable in the public sector. Conclusion The basket of WHO essential medicines for priority conditions for children under 5 years were accessible, available and affordable in the eThekwini Metropolitan areas. This was the first study in eThekwini to determine access to the WHO basket of priority medicines for children and can be scaled-up to a national study to provide a holistic comparison of these medicines in the country, and also for global comparison. |
| first_indexed | 2024-03-09T02:07:49Z |
| format | Article |
| id | doaj.art-a5234e933ab64b2e9c74b5ef7ffd0d03 |
| institution | Directory Open Access Journal |
| issn | 2052-3211 |
| language | English |
| last_indexed | 2024-03-09T02:07:49Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj.art-a5234e933ab64b2e9c74b5ef7ffd0d032023-12-07T15:28:04ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112022-12-0115110.1186/s40545-021-00402-y12315308The availability of priority medicines for children under 5 years in eThekwini, South AfricaShannice Mahadeo0Keshmika Narain1Lungelo Mhlongo2Desmaine Chetty3Lindelani Masondo4Mandla Zungu5Fatima Suleman6Velisha Ann Perumal-Pillay7Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Discipline of Pharmaceutical Sciences,Background Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study investigated accessibility, availability and affordability of a basket of priority medicines for children under 5 years in public and private healthcare sector pharmacies in the eThekwini Metropolitan area in Durban, South Africa. Methods The WHO/HAI survey tool for assessing medicine prices, availability and affordability was adapted and employed for a basket of WHO Priority life-saving medicines for children under 5 years. Six district hospitals in the north, south and central eThekwini Metropolitan were selected as major facility reference points and for data collection and pharmacies within a 5 km radius from each major facility were also invited to participate in the study, as outlined in the WHO/HAI tool methodology. Of the 58 pharmacies selected, a total of 27 pharmacies from both private and public healthcare sectors agreed to participate and were surveyed, representing a 47% response rate. Data was analysed using Microsoft excel. Results All participating pharmacies (and hence the selected basket of priority medicines at these facilities) were deemed accessible. Overall the public sector had more medicines available on the shelf (averaging 64%) than the private sector (48%) which had more medicines available on order (84%). At least one medicine for each of the eight (8) conditions was available at both sectors which meant patients could be treated for these conditions. Medicines for priority conditions (except HIV, which was a 28-day course) were deemed affordable as these regimens were obtainable within a day’s wage for the lowest paid unskilled worker. Priority medicines for children under 5 years were more available and more affordable in the public sector. Conclusion The basket of WHO essential medicines for priority conditions for children under 5 years were accessible, available and affordable in the eThekwini Metropolitan areas. This was the first study in eThekwini to determine access to the WHO basket of priority medicines for children and can be scaled-up to a national study to provide a holistic comparison of these medicines in the country, and also for global comparison.http://dx.doi.org/10.1186/s40545-021-00402-yessential medicines listspriority medicineschildren under 5 yearsavailabilityaffordability |
| spellingShingle | Shannice Mahadeo Keshmika Narain Lungelo Mhlongo Desmaine Chetty Lindelani Masondo Mandla Zungu Fatima Suleman Velisha Ann Perumal-Pillay The availability of priority medicines for children under 5 years in eThekwini, South Africa Journal of Pharmaceutical Policy and Practice essential medicines lists priority medicines children under 5 years availability affordability |
| title | The availability of priority medicines for children under 5 years in eThekwini, South Africa |
| title_full | The availability of priority medicines for children under 5 years in eThekwini, South Africa |
| title_fullStr | The availability of priority medicines for children under 5 years in eThekwini, South Africa |
| title_full_unstemmed | The availability of priority medicines for children under 5 years in eThekwini, South Africa |
| title_short | The availability of priority medicines for children under 5 years in eThekwini, South Africa |
| title_sort | availability of priority medicines for children under 5 years in ethekwini south africa |
| topic | essential medicines lists priority medicines children under 5 years availability affordability |
| url | http://dx.doi.org/10.1186/s40545-021-00402-y |
| work_keys_str_mv | AT shannicemahadeo theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT keshmikanarain theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT lungelomhlongo theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT desmainechetty theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT lindelanimasondo theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT mandlazungu theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT fatimasuleman theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT velishaannperumalpillay theavailabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT shannicemahadeo availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT keshmikanarain availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT lungelomhlongo availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT desmainechetty availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT lindelanimasondo availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT mandlazungu availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT fatimasuleman availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica AT velishaannperumalpillay availabilityofprioritymedicinesforchildrenunder5yearsinethekwinisouthafrica |